SCHEMBL29680642

SCHEMBL29680642

O=C1C[C@]2(CCCNC2)N1

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
NEK2 P51955 1/20 0.32
HTR2A P28223 1/20 0.31
POLB P06746 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680164 1.00 CRBN (0.34) CRBNSIGMAR1NEK2HTR2APOLB
SCHEMBL24536621 0.94 CRBN (0.33) CRBNSIGMAR1NEK2POLBALDH1A1
SCHEMBL30887278 0.83 CRBN (0.40) CRBNNEK2
Hydrochloric Acid SCHEMBL31270250 0.82 CRBN (0.39) CRBNSIGMAR1
Hydrochloric Acid SCHEMBL15441503 0.80 CRBN (0.38) CRBNSIGMAR1
SCHEMBL19946508 0.76
SCHEMBL1401020 0.76
SCHEMBL24537298 0.75
SCHEMBL24535221 0.75
SCHEMBL4925004 0.74 POLB (0.47) CRBNPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4262807-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-10-25 EP disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 WO disclosed